Merck
MRK
#55
Rank
ยฃ201.25 B
Marketcap
ยฃ80.58
Share price
1.78%
Change (1 day)
3.06%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): ยฃ5.76

According to Merck's latest financial reports the company's current EPS (TTM) is ยฃ5.55. In 2024 the company made an earnings per share (EPS) of ยฃ4.94 an increase over its 2023 EPS that were of ยฃ0.11.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ5.7616.63%
2024ยฃ4.944308.46%
2023ยฃ0.11-97.32%
2022ยฃ4.1910.92%
2021ยฃ3.7784.68%
2020ยฃ2.04-27.2%
2019ยฃ2.8163.44%
2018ยฃ1.72151.11%
2017ยฃ0.68-54.58%
2016ยฃ1.5130.21%
2015ยฃ1.16-61.99%
2014ยฃ3.04180.51%
2013ยฃ1.08-31.82%
2012ยฃ1.596.62%
2011ยฃ1.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ7.63 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.38-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ1.26-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ5.89 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ14.99 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ9.52 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ2.71-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
ยฃ2.17-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.63-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ0.46-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel